Jazz Pharmaceuticals plc (JAZZ): Total Assets
$11.66B
As of 2025-12-31
$11.08B
As of 2026-06-30
+2.5%
3-year compound annual growth
+12.3%
5-year compound annual growth
+13.3%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.66B | -2.9% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $12.01B | +5.4% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $11.39B | +5.2% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $10.84B | -11.9% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $12.30B | +88.2% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $6.54B | +18.0% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $5.54B | +6.4% | 2021-02-23, Balance as of period end |
| 2018-12-31 | $5.20B | +1.6% | 2020-02-25, Balance as of period end |
| 2017-12-31 | $5.12B | +6.7% | 2019-02-26, Balance as of period end |
| 2016-12-31 | $4.80B | +44.0% | 2018-02-27, Balance as of period end |
| 2015-12-31 | $3.33B | -0.2% | 2017-02-28, Balance as of period end |
| 2014-12-31 | $3.34B | +49.2% | 2016-02-23, Balance as of period end |
| 2013-12-31 | $2.24B | +13.8% | 2015-02-24, Balance as of period end |
| 2012-12-31 | $1.97B | +675.5% | 2014-02-25, Balance as of period end |
| 2011-12-31 | $253.57M | +86.8% | 2013-02-26, Balance as of period end |
| 2010-12-31 | $135.73M | n/a | 2012-02-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $11.66B | -2.9% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $8.54B | -11.5% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $13.36B | +5.9% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $4.97B | +17.1% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $8.19B | +38.3% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $7.59B | +8.7% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.88B | +7.0% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $3.68B | +5.1% |
| Organon & Co. (OGN) | 2025-12-31 | $12.87B | -1.8% |
Compare JAZZ, PRGO, ELAN, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗